LLY
2024Q4BMOEli Lilly and Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
Street
Consensus EPS5.067
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move2.1%
IV front—
P/C full—
P/C front—
Features as of2025-02-05
Run-up
Close—
Ret 5d+4.7%
Ret 10d+11.7%
Ret 20d+10.1%
Ret 30d+11.2%
Actual EPS
5.32Beat
Estimated EPS5.067
Actual revenue
13.5B
Surprise %+5.0%
Beat / missBeat
Beat streak 41
Beat streak 81
Reaction
1-day stock reaction+3.7%
Implied vs actual
Implied 2.1%Actual 0.3%
Gap reaction-0.3%
Day result+3.3%
Next-day upYes
Realized / IV0.15×
Post tape
Post 5d+0.2%
Post 10d+0.4%
Post volume7.1M
Vol ×10d2.18×
Vol ×20d1.76×
Post range6.2%